定义至关重要:采用SMFM生物测量标准与ISUOG/Delphi共识标准产前诊断晚发型胎儿生长受限的检出率与围产结局
该回顾性队列研究纳入2014年1月至2020年12月在澳大利亚布里斯班Mater Mother's Hospital转诊并足月分娩的非畸形单胎孕妇,比较SMFM生物测量标准(EFW或AC<10th百分位)与ISUOG/Delphi共识标准筛查晚发型FGR(≥32周诊断)对SGA儿、因NRFS急诊剖宫产、围产儿死亡及复合严重新生儿病率的筛查性能。两种标准共分类1030例为晚发型FGR,其中400例两种标准均分类,548例仅SMFM分类,82例仅ISUOG/Delphi分类。SMFM和ISUOG/Delphi标准产前检出晚发型FGR均与出生体重<10th百分位(SMFM:aOR 133.0,95%CI 94.7-186.6;ISUOG/Delphi:aOR 69.5,95%CI 49.1-98.2)及<3rd百分位(SMFM:aOR 348.7,95%CI 242.6-501.2;ISUOG/Delphi:aOR 215.4,95%CI 148.4-312.7)分娩几率升高相关。与SMFM标准相比,ISUOG/Delphi标准预测出生体重<10th百分位SGA儿的几率更低(aOR 0.5,95%CI 0.3-0.8),但预测因NRFS急诊剖宫产(aOR 2.30,95%CI 1.14-4.66)和复合新生儿病率(aOR 1.22,95%CI 1.05-1.41)的几率更高。两种标准对出
要点
- SMFM和ISUOG/Delphi标准产前检出晚发型FGR均与出生体重<10th百分位分娩几率升高相关(aOR分别为133.0和69.5)。
- SMFM和ISUOG/Delphi标准产前检出晚发型FGR均与出生体重<3rd百分位分娩几率升高相关(aOR分别为348.7和215.4)。
- 与SMFM标准相比,ISUOG/Delphi标准预测出生体重<10th百分位SGA儿的几率更低(aOR 0.5,95%CI 0.3-0.8)。
- 与SMFM标准相比,ISUOG/Delphi标准预测因NRFS急诊剖宫产(aOR 2.30,95%CI 1.14-4.66)和复合新生儿病率(aOR 1.22,95%CI 1.05-1.41)的几率更高。
- 两种标准对复合严重新生儿病率或NRFS急诊剖宫产预测的LR+<10;仅SMFM生物测量标准(尤其AC<3rd百分位)对围产儿死亡预测的LR+值最高。
适用人群与场景
- 2014年1月至2020年12月在澳大利亚布里斯班Mater Mother's Hospital转诊并足月分娩的非畸形单胎孕妇。
- 晚发型FGR定义为≥32周诊断。
诊断标准与关键阈值
- SMFM生物测量标准:估计胎儿体重(EFW)或腹围(AC)<10th百分位。
- 晚发型FGR诊断时间:≥32周。
研究设计与关键结果
- 研究类型:回顾性队列研究;人群:非畸形单胎足月分娩孕妇;干预/暴露:按SMFM标准和ISUOG/Delphi标准分类晚发型FGR;对照:两种标准间比较。
- 两种标准共分类1030例为晚发型FGR:400例两种标准均分类,548例仅SMFM分类,82例仅ISUOG/Delphi分类。
- SMFM标准产前检出晚发型FGR与出生体重<10th百分位分娩相关:aOR 133.0(95%CI 94.7-186.6)。
- ISUOG/Delphi标准产前检出晚发型FGR与出生体重<10th百分位分娩相关:aOR 69.5(95%CI 49.1-98.2)。
- SMFM标准产前检出晚发型FGR与出生体重<3rd百分位分娩相关:aOR 348.7(95%CI 242.6-501.2)。
- ISUOG/Delphi标准产前检出晚发型FGR与出生体重<3rd百分位分娩相关:aOR 215.4(95%CI 148.4-312.7)。
- 与SMFM标准相比,ISUOG/Delphi标准预测出生体重<10th百分位SGA儿的aOR为0.5(95%CI 0.3-0.8)。
- 与SMFM标准相比,ISUOG/Delphi标准预测因NRFS急诊剖宫产的aOR为2.30(95%CI 1.14-4.66),预测复合新生儿病率的aOR为1.22(95%CI 1.05-1.41)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,SMFM和ISUOG/Delphi标准对出生体重<10th或<3rd百分位婴儿检测均具有较强筛查潜力,但对不良新生儿结局筛查潜力不强。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Fetal growth restriction (FGR) is often secondary to placental dysfunction and is suspected prenatally based on biometric or circulatory abnormalities detected on ultrasound. The aims of this study were to compare the screening performance of the Society for Maternal-Fetal Medicine (SMFM) biometric criteria (estimated fetal weight (EFW) or abdominal circumference (AC) < 10th centile) with that of the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG)-endorsed Delphi consensus criteria for late FGR for delivery of a small-for-gestational-age (SGA) infant at term, emergency Cesarean section (CS) for non-reassuring fetal status (NRFS), perinatal mortality and composite severe neonatal morbidity.
METHODS: We classified retrospectively non-anomalous singleton infants as having late FGR (diagnosed ≥ 32 weeks) according to SMFM and ISUOG/Delphi criteria in a cohort of women who had been referred to the Mater Mother's Hospital, Brisbane, Australia and who delivered at term between January 2014 and December 2020. The study outcomes were delivery of a SGA infant (birth weight (BW) < 10th or < 3rd centile), emergency CS for NRFS, perinatal mortality (defined as stillbirth or neonatal death within 28 days of a live birth) and a composite of severe neonatal morbidity. We assessed the screening performance of various ultrasound variables by calculating the sensitivity, specificity, positive (PPV) and negative (NPV) predictive values, false-positive and false-negative rates, positive likelihood ratio (LR+) and negative likelihood ratio.
RESULTS: The SMFM and ISUOG/Delphi consensus criteria collectively classified 1030 cases as having late FGR. Of these, 400 cases were classified by both SMFM and ISUOG/Delphi criteria, whilst 548 cases were classified using only SMFM criteria and 82 cases were classified only by ISUOG/Delphi criteria. Prenatal detection of late FGR by SMFM and ISUOG/Delphi criteria was associated with increased odds of delivery of an infant with BW < 10th centile (SMFM: adjusted odds ratio (aOR), 133.0 (95% CI, 94.7-186.6); ISUOG/Delphi: aOR, 69.5 (95% CI, 49.1-98.2)) or BW < 3rd centile (SMFM: aOR, 348.7 (95% CI, 242.6-501.2); ISUOG/Delphi: aOR, 215.4 (95% CI, 148.4-312.7)). Compared with the SMFM criteria, the ISUOG/Delphi criteria were associated with lower odds (aOR, 0.5 (95% CI, 0.3-0.8)) of predicting a SGA infant with BW < 10th centile, but higher odds of predicting emergency CS for NRFS (aOR, 2.30 (95% CI, 1.14-4.66)) and composite neonatal morbidity (aOR, 1.22 (95% CI, 1.05-1.41)). Both SMFM and ISUOG/Delphi criteria were associated with high LR+, specificity, PPV and NPV for the prediction of infants with BW < 10th and BW < 3rd centile. However, both methods functioned much less efficiently for the prediction of composite severe neonatal morbidity or emergency CS for NRFS, with LR+ < 10. The SMFM biometric criteria alone, particularly AC < 3rd centile, had the highest LR+ values for the prediction of perinatal mortality.
CONCLUSION: Both the SMFM and ISUOG/Delphi criteria had strong screening potential for the detection of infants with BW < 10th or < 3rd centile but not for adverse neonatal outcome. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
参考来源
- Schreiber V, Hurst C, da Silva Costa F, et al. Definitions matter: detection rates and perinatal outcome for infants classified prenatally as having late fetal growth restriction using SMFM biometric vs ISUOG/Delphi consensus criteria. Ultrasound Obstet Gynecol. 2023. PMID: 35866888. doi:10.1002/uog.26035
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。